Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients.
Johansson J, Kiffin R, Andersson A, Lindnér P, Naredi PL, Olofsson Bagge R, Martner A. Johansson J, et al. Front Oncol. 2018 Dec 3;8:570. doi: 10.3389/fonc.2018.00570. eCollection 2018. Front Oncol. 2018. PMID: 30560089 Free PMC article.
Hyperthermic isolated limb perfusion with melphalan (M-ILP) is a treatment option for melanoma patients with metastases confined to the limbs. ...We conclude that melphalan-exposed melanoma cells trigger expansion of …
Hyperthermic isolated limb perfusion with melphalan (M-ILP) is a treatment option for melanoma patient
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.
Johansson J, Kiffin R, Aydin E, Nilsson MS, Hellstrand K, Lindnér P, Naredi P, Olofsson Bagge R, Martner A. Johansson J, et al. Oncoimmunology. 2019 Nov 3;9(1):1684126. doi: 10.1080/2162402X.2019.1684126. eCollection 2020. Oncoimmunology. 2019. PMID: 32002296 Free PMC article.
Hyperthermic isolated limb perfusion (ILP) with high-dose melphalan is a treatment option for melanoma patients with metastasis confined to limbs (in-transit metastasis). ...Furthermore, melphalan-exposed melanoma cells t
Hyperthermic isolated limb perfusion (ILP) with high-dose melphalan is a treatment option for melanoma